No Data
Retail Investors Invested in Zhejiang Zhongxin Fluoride Materials Co.,Ltd (SZSE:002915) Copped the Brunt of Last Week's CN¥1.0b Market Cap Decline
Investors in Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) From Three Years Ago Are Still Down 44%, Even After 10% Gain This Past Week
10 consecutive trading limits! The big monster stock makes a comeback.
What exactly are you speculating about?
Zhejiang Zhongxin Fluoride Materials (002915.SZ): The company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development.
Gelonghui October 18th: Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development. Pharmaceutical intermediates are important chemical raw materials in the drug synthesis process, playing a key role in the research and development of new drugs. Currently, the company has formed pharmaceutical intermediates represented by the 2,3,4,5-tetrafluorobenzene series, nanosar acid, and trifluoroacetic acid series. It has a provincial-level small and medium-sized enterprise technology center, a provincial-level enterprise research institute - Zhejiang Zhongxin Fluoride Chemicals and New Materials Research Institute, dedicated to pharmaceutical intermediates.
Zhongxin Fluoride: Report for the third quarter of 2024
Zhejiang Zhongxin Fluoride Materials (002915.SZ) released its performance for the first three quarters, with a net loss of 42.99 million yuan.
zhejiang zhongxin fluoride materials (002915.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhejiang Zhongxin Fluoride Materials Co.,Ltd (SZSE:002915) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
